Rabeprazole Sodium

CAS 117976-90-6 17 API suppliersSmall Molecule

Overview

Rabeprazole Sodium is a proton pump inhibitor that suppresses gastric acid secretion by specific inhibition of the H+/K+-ATPase enzyme system at the secretory surface of the gastric parietal cell. It is widely used in the treatment of gastroesophageal reflux disease (GERD), duodenal ulcers and Zollinger-Ellison syndrome.

API suppliers (17)

Suppliers of Rabeprazole Sodium evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.

Where these suppliers are
India9Spain1Taiwan1USA1

Country recorded for 12 of 17 suppliers.

10 of 17 hold a GMP certificate on record in the EU or UK registers

Therapeutic areas

Gastroenterology
Verified Supplier Partner

Do you supply Rabeprazole Sodium? Get in front of buyers actively sourcing it.

We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.

No cost to enquire · we only reach out with a fit.

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.